INVO Fertility posts new investor presentation

INVO Fertility, Inc. furnished an investor presentation that it plans to use at the Planet MicroCap Conference on June 17, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

INVO Fertility, Inc. furnished an investor presentation that it plans to use at the Planet MicroCap Conference on June 17, 2026. The presentation covers the company’s current and long-term operations, performance and industry conditions, and was posted on the investor section of its website on June 16, 2026.

The slides are included as Exhibit 99.1 to this report. The material is furnished under Regulation FD, not filed, meaning it is not subject to certain Exchange Act liabilities and is not automatically incorporated into other securities filings unless specifically referenced.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Conference date: June 17, 2026 Furnishing date: June 16, 2026 Exhibit number: 99.1 +1 more

4 metrics

Conference date June 17, 2026 Planet MicroCap Conference presentation date

Furnishing date June 16, 2026 Date presentation was posted on investor website

Exhibit number 99.1 INVO Fertility Corporate Presentation exhibit identifier

Cover data file exhibit 104 Cover Page Interactive Data File in Inline XBRL

Key Terms

Regulation FD, forward-looking statements, Emerging growth company, Exchange Act, +1 more

5 terms

Regulation FD regulatory

"Item 7.01 Regulation FD Disclosure. INVO Fertility, Inc. (the “Company”) is furnishing a copy of an investor presentation"

Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.

forward-looking statements regulatory

"Exhibit 99.1 furnished herewith contains statements intended as “forward-looking statements” that are subject to the cautionary language"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Emerging growth company regulatory

"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (CFR §240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Exchange Act regulatory

"shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)"

A federal law that sets rules for trading securities on public exchanges, requiring companies and market participants to register, disclose regular financial information, and follow standards that promote honest, orderly markets. For investors, it matters because it creates transparency and legal protections—like stopping insider trading and ensuring timely company disclosures—so you can evaluate risks and rely on consistent rules much as players rely on a referee to keep a game fair.

Exhibit 99.1 financial

"Exhibit 99.1 | | INVO Fertility Corporate Presentation"

Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did INVO Fertility (IVF) disclose in this 8-K filing?

INVO Fertility furnished an investor presentation as an exhibit to this 8-K. The slides outline current and long-term operations, performance and industry conditions and will be used at the Planet MicroCap Conference, providing a structured overview of the company for investors.

When will INVO Fertility (IVF) present this investor deck?

INVO Fertility intends to use the investor presentation at the Planet MicroCap Conference on June 17, 2026. This conference appearance gives management a platform to explain operations, performance and market positioning directly to institutional and retail investors.

Where can investors access INVO Fertility’s new presentation?

Investors can view the presentation in two places: it is posted in the Investors section of www.invofertility.com and attached as Exhibit 99.1 to this report. Both sources contain the same slide materials furnished under Regulation FD.

Is INVO Fertility’s Exhibit 99.1 considered filed with the SEC?

No. The company explicitly states that the information under Item 7.01, including Exhibit 99.1, is furnished, not filed. As a result, it is not subject to Section 18 Exchange Act liabilities or automatically incorporated into other securities filings.

Does INVO Fertility’s presentation include forward-looking statements?

Yes. The company notes that Exhibit 99.1 contains forward-looking statements. These statements are subject to cautionary language within the exhibit, reminding investors that projections about operations, performance or industry conditions involve risks and uncertainties.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/16/2026 - 05:00 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 16, 2026

INVO FERTILITY, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-39701		20-4036208
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

5582 Broadcast Court

Sarasota, Florida 34240

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (978) 878-9505

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Each Exchange on Which Registered
Common Stock, $0.0001 par value		IVF		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (CFR §240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

INVO Fertility, Inc. (the “Company”) is furnishing a copy of an investor presentation (the “Presentation”) that the Company intends to use, in whole or in part, during the Company’s presentation at the Planet MicroCap Conference on June 17, 2026. The Presentation addresses the Company’s current and long-term operations, performance and industry conditions. On June 16, 2026, the Company posted a copy of the Presentation to the “Investors” portion of its website (www.invofertility.com). These slides are attached to this Current Report on Form 8-K as Exhibit 99.1.

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1. In addition, Exhibit 99.1 furnished herewith contains statements intended as “forward-looking statements” that are subject to the cautionary language about forward-looking statements set forth in such exhibit.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description

99.1		INVO Fertility Corporate Presentation
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 16, 2026